Latest filing published 19 Aug 2026 for EQL Pharma AB, €48k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Allan Sylvest Aasberg: trading record in brief
This profile gathers the share dealings of Allan Sylvest Aasberg in EQL Pharma AB. We count 2 filings, every one of them for a trade on 14 August 2026.
On the market, this insider has only ever bought: 2 purchases, €95k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 19 August 2026 came the latest disclosure, an open-market purchase for €48k in EQL Pharma AB. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Allan Sylvest Aasberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ SEK 26.36AktieISIN SE0005497732FI:csv-f549ec71932406ec2dd2Canonical exit: 12 Nov 2026 (T+90)
- 20,000 shares@ SEK 26.360.068% mcap100.0% of flowAktieISIN SE0005497732FI:csv-bdac4202ec394da54509Canonical exit: 12 Nov 2026 (T+90)
2 of 2 declarations